Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02612285
Title Study of SNX-5422 in TP53 Null Cancers
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Esanex Inc.
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

SNX-5422

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST